Patient P-02262
Synthetic patientMETA-24 · Day 178 · 45–54 · M · baseline S16Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
15%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S16
- Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 13.
Primary contributors, last 14 days
- Toxicity+14
- Inflammatory activity+12
- Treatment adherence+8
- GI instability-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable75 min
stable · -2.0 vs previous 14 d
Sleep duration
Wearable5.1 h
worsening · -0.3 vs previous 14 d
Energy level
Daily log4.7/10
stable · -0.1 vs previous 14 d
Steps
Wearable8,206
stable · -307 vs previous 14 d
GI burden
Companion19.1/100
stable · +0.6 vs previous 14 d
Adherence
Companion98.2 %
improving · +5.1 vs previous 14 d
Sleep quality
Wearable26.2/100
worsening · -5.4 vs previous 14 d
Glucose, CGM daily mean
CGM142 mg/dL
stable · +4.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 65 from the failing basin, 29 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.2 next day on high-intake days · n 22
Would not help
- Keep fat lowGI +3.4 next day on high-intake days · n 21
- Keep simple carbs lowGI +2.2 next day on high-intake days · n 14
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Dietary fat load+3.4detractor · 95%
- Protein-3.2supporter · 95%
- Simple carbohydrates+2.2detractor · 77%
- Ultra-processed food+1.5no signal · 49%
- Caffeine-0.3no signal · 15%
- Alcohol-0.2no signal · 15%
- Histamine load-0.1no signal · 15%
- Insoluble fibre0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓45
- WearableResting HR 75 bpm
- WearableShort sleep window
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 34/100
- Mucosal barrier integrity ↓10
- WearableSleep 5.1 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 2.4 · butyrate capacity 34/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 44 ms
- Sleep
- 5.8 h
- Steps
- 8,259
- Resting HR
- 73 bpm
Daily log: GI score 19, nutritional resilience 63, adherence 98.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02093 | 35% | S05 | AD-05 | no change | 40 |
| P-02285 | 35% | S14 | AD-05 | no change | 39 |
| P-02031 | 33% | S12 | AD-05 | improved | 47 |
| P-02267 | 38% | S09 | BR-03 | no change | 45 |
| P-02483 | 38% | S06 | BR-03 | no change | 64 |
| P-02087 | 37% | S01 | BR-03 | no change | 40 |
| P-02280 | 36% | S07 | BR-03 | no change | 50 |
| P-02522 | 33% | S01 | BR-03 | no change | 40 |
| P-02564 | 32% | S15 | BR-03 | improved | 32 |
| P-02354 | 32% | S01 | CR-01 | improved | 78 |
| P-02274 | 54% | S15 | DT-01 | improved | 50 |
| P-02235 | 51% | S14 | DT-01 | improved | 50 |